MRSN - Mersana Therapeutics Inc
IEX Last Trade
1.57
0.050 3.185%
Share volume: 479,849
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.52
0.05
3.29%
Summary score
25%
Profitability
25%
Dept financing
19%
Liquidity
65%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-42.12%
Return on assets
-15.07%
Return on sales
-138478.24%
Return on invested capital
141.74%
Total debt ratio
49.32%
Debt ratio change over timeo
-0.35%
Current Ratio
5.51%
Quick Ratio
5%
Cash Position Ratio
5.34%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-65.56%
Return on assets
-12.9%
Return on sales
-354.29%
Return on invested capital
62.07%
Total debt ratio
80.21%
Debt ratio change over timeo
0.34%
Current Ratio
3.63%
Quick Ratio
3.63%
Cash Position Ratio
3.52%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-68.99%
Return on assets
-10.59%
Return on sales
-227.16%
Return on invested capital
45.35%
Total debt ratio
85.89%
Debt ratio change over time
1.27%
Current Ratio
3.51%
Quick Ratio
3.51%
Cash Position Ratio
3.43%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-153.74%
Return on assets
-115.36%
Return on sales
-86614.24%
Return on invested capital
3.7%
Total debt ratio
-35.45%
Debt ratio change over time
-0.35%
Current Ratio
3.43%
Quick Ratio
3.62%
Cash Position Ratio
3.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MRSN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -42.12% | 13.79% | 34.47% | 7.43% |
| Return on assets | -15.07% | 2.76% | 3.15% | 5.62% |
| Return on sales | -138478.24% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 141.74% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 59% |
| Total debt ratio | 49.32% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.35% | 308.97% | -6.99% | 1.18% |
| Dept financing | 14% | 50% | 25% | 7% |
| Current Ratio | 3.63% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.63% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.52% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 21% | 48% |
| Short-term ratios | MRSN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -65.56% | 13.77% | 13.25% | 3.8% |
| Return on assets | -12.9% | 2.43% | 1.89% | 3.09% |
| Return on sales | -354.29% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 62.07% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 66% | 60% | 61% |
| Total debt ratio | 80.21% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 0.34% | 46.38% | -72.08% | 1.51% |
| Dept financing | 22% | 50% | 25% | 7% |
| Current Ratio | 3.63% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.63% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.52% | 0.36% | 1.28% | 2.93% |
| Liquididy | 61% | 11% | 29% | 71% |